| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $982K | — | -54.8% |
| R&D Expense | $21.9M | — | -26.5% |
| SG&A Expense | $8.2M | — | -4.8% |
| Operating Income | -$29.1M | — | +19.6% |
| Interest Expense | $689K | — | +1.5% |
| Net Income | -$28.7M | — | +16.0% |
| EPS (Basic) | -$0.22 | — | +15.4% |
| EPS (Diluted) | -$0.22 | — | +15.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $128.1M | -16.0% | -16.9% |
| Current Assets | $132.8M | -15.5% | -47.9% |
| Total Assets | $202.0M | -11.7% | -39.3% |
| Current Liabilities | $20.0M | +6.8% | -33.0% |
| Long-term Debt | $32.7M | +0.4% | +1.5% |
| Total Liabilities | $105.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.3M | — | +35.4% |
| Capital Expenditures | $70K | — | -95.4% |
| Investing Cash Flow | -$70K | — | -100.5% |
| Financing Cash Flow | -$525K | — | +0.0% |
| Free Cash Flow | -$24.3M | — | +37.8% |
| -14.2% |
| Stockholders' Equity | $96.9M | -21.3% | -53.9% |